當(dāng)前位置：首頁(yè) JCRQ2 期刊介紹(非官網(wǎng))

Transplant Infectious DiseaseSCIE

國(guó)際簡(jiǎn)稱：TRANSPL INFECT DIS 參考譯名：移植傳染病

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：1398-2273; E-ISSN：1399-3062; 是否OA：未開(kāi)放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Wiley-Blackwell Publishing Ltd; 出版語(yǔ)言：English; 出版周期：Quarterly; 出版年份：1999; 研究方向：傳染病學(xué)-醫(yī)學(xué)

評(píng)價(jià)信息：: 影響因子：2.6; H-index：60; CiteScore指數(shù)：5.3; SJR指數(shù)：0.62; SNIP指數(shù)：0.628

發(fā)文數(shù)據(jù)：: Gold OA文章占比：18.67%; 研究類(lèi)文章占比：73.33%; 年發(fā)文量：150

投稿咨詢加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介Transplant Infectious Disease期刊介紹

Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal.

Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import.

期刊簡(jiǎn)介Transplant Infectious Disease期刊介紹

《Transplant Infectious Disease》自1999出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：偏慢,4-8周
醫(yī)學(xué)
IMMUNOLOGY
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Transplant Infectious Disease Cite Score數(shù)據(jù)

CiteScore：5.3
SJR：0.62
SNIP：0.628

學(xué)科類(lèi)別	分區(qū)	排名	百分位
大類(lèi)：Medicine 小類(lèi)：Transplantation	Q2	16 / 54	71%
大類(lèi)：Medicine 小類(lèi)：Infectious Diseases	Q2	135 / 344	60%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Transplant Infectious Disease 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類(lèi)學(xué)科	分區(qū)	小類(lèi)學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	IMMUNOLOGY 免疫學(xué) INFECTIOUS DISEASES 傳染病學(xué) TRANSPLANTATION 移植	4區(qū) 4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類(lèi)似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書(shū)管理及圖書(shū)情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Transplant Infectious Disease JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：IMMUNOLOGY	SCIE	Q3	127 / 181	30.1%
學(xué)科：INFECTIOUS DISEASES	SCIE	Q3	69 / 132	48.1%
學(xué)科：TRANSPLANTATION	SCIE	Q2	13 / 31	59.7%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：IMMUNOLOGY	SCIE	Q3	101 / 181	44.48%
學(xué)科：INFECTIOUS DISEASES	SCIE	Q2	64 / 132	51.89%
學(xué)科：TRANSPLANTATION	SCIE	Q3	17 / 31	46.77%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門(mén)類(lèi)和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Infection evaluation in the early period after liver transplantation: A single-center exploration
Author: Tu, Zhen-Hua; Jin, Ping-Bo; Chen, Di-Yu; Chen, Zhi-Yun; Li, Zhi-Wei; Zhang, Bao-Shan; Zhang, Lin; Zhang, Wei; Bai, Xue-Li; Liang, Ting-Bo

Journal: TRANSPLANT INFECTIOUS DISEASE. 2023; Vol. 25, Issue 2, pp. -. DOI: 10.1111/tid.14002
2、Adenovirus infection diagnosed by metagenomic next-generation sequencing after haploidentical hematopoietic stem cell transplantation: A multicenter study in China
Author: Wu, Qiong; Wu, Yanjun; Zhao, Ye; Zhang, Yanming; Cao, Junjie; Wu, Depei; Zhou, Juying; Chen, Feng

Journal: TRANSPLANT INFECTIOUS DISEASE. 2023; Vol. 25, Issue 2, pp. -. DOI: 10.1111/tid.14054
3、Role of regulatory T cells in CD47/donor-specific transfusion-induced immune tolerance in skin-heart transplantation mice.
Author: Hu Y¹, Zhou H², Gao B², Wang G², Wang Y².

Journal: Transpl Infect Dis. 2019 Feb;21(1):e13012. doi: 10.1111/tid.13012. Epub 2018 Nov 9.
4、Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients.
Author: Huang H¹, Tang H¹, Deng H¹, Shen J¹, Zhou Q¹, Xie W¹, Wu J¹, Chen J¹.

Journal: Transpl Infect Dis. 2019 Feb;21(1):e13018. doi: 10.1111/tid.13018. Epub 2018 Nov 22.
5、Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta-analysis.
Author: Liu J^1,², Ma B², Cao W², Li M², Bramer WM³, Peppelenbosch MP², Pan Q^1,².

Journal: Transpl Infect Dis. 2019 Apr;21(2):e13047. doi: 10.1111/tid.13047. Epub 2019 Jan 21.
6、Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Author: Qiu KY^1,², Liao XY^1,², Fang JP^1,², Xu HG^1,², Li Y^1,², Huang K^1,², Zhou DH^1,².

Journal: Transpl Infect Dis. 2019 Mar 12:e13066. doi: 10.1111/tid.13066. [Epub ahead of print]
7、A first report of leptospirosis after liver transplantation
Author: alicetwsong

Journal: Transplant Infectious Disease, 2016.
8、Late
Author: huangxiaojun

Journal: Transplant Infectious Disease, 2016.